LuseogliflozinMAFLDMetabolic Associated Fatty Liver Disease (MAFLD)type 2 diabetes mellitus (T2DM)T2DM
… control remained at F4. (IDDF2026-ABS-0196 Table 1)Conclusions Luseogliflozin added to standard therapy improved liver fibrosis scores, glyce…
Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
… control remained at F4. (IDDF2026-ABS-0196 Table 1)Conclusions Luseogliflozin added to standard therapy improved liver fibrosis scores, glyce…